Prognostic Factors Associated With Increased Mortality in Pediatric Veno‐Occlusive Disease Following Hematopoietic Cell Transplantation
Severe VOD in pediatric patients following HCT remains a life-threatening complication with a high mortality rate. Early diagnosis and treatment with defibrotide are critical for managing this condition. In our cohort, the addition of steroids to defibrotide was not associated with improved outcomes.
Authors
- Adi Avniel Aran (ORCID: https://orcid.org/0000-0001-9460-4689)
- Polina Stepensky (ORCID: https://orcid.org/0000-0002-4923-3660)
- Aharon Gefen
- Irina Zaidman
- Ehud Even‐Or (ORCID: https://orcid.org/0000-0002-4292-6376)
- N. J. Barsoum
- M. Daher
Institutions
- Hebrew University of Jerusalem (IL)
- Hadassah Medical Center (IL)
- Rambam Health Care Campus (IL)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1111/ctr.70037
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.45